☆ 4.7 Letter

Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series

ANNALS OF INTERNAL MEDICINE (2021)

期刊

ANNALS OF INTERNAL MEDICINE

卷 174, 期 9, 页码 1334-+

出版社

AMER COLL PHYSICIANS

DOI: 10.7326/M21-1976

关键词

-

类别

Medicine, General & Internal

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, General & Internal

Acute Vertigo After COVID-19 Vaccination: Case Series and Literature Review

Paola Di Mauro, Ignazio La Mantia, Salvatore Cocuzza, Pasqua Irene Sciancalepore, Deborak Rasa, Antonino Maniaci, Salvatore Ferlito, Isabella Tundo, Roberta Anzivino

Summary: This study presents cases of acute vertigo potentially linked to COVID-19 vaccination and reviews the available literature on cochleovestibular dysfunction after vaccination. The evaluation of 33 patients with acute vertigo after COVID-19 vaccination revealed various associated symptoms, with some patients showing pathognomonic nystagmus for benign paroxysmal positional vertigo. The presence of non-peripheral nystagmus suggests a potential central nervous system involvement.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

Stephanie A. Richard, Simon D. Pollett, Anthony C. Fries, Catherine M. Berjohn, Ryan C. Maves, Tahaniyat Lalani, Alfred G. Smith, Rupal M. Mody, Anuradha Ganesan, Rhonda E. Colombo, David A. Lindholm, Michael J. Morris, Nikhil Huprikar, Christopher J. Colombo, Cristian Madar, Milissa Jones, Derek T. Larson, Samantha E. Bazan, Katrin Mende, David Saunders, Jeffrey Livezey, Charlotte A. Lanteri, Ann I. Scher, Celia Byrne, Jennifer Rusiecki, Evan Ewers, Nusrat J. Epsi, Julia S. Rozman, Caroline English, Mark P. Simons, David R. Tribble, Brian K. Agan, Timothy H. Burgess

Summary: Understanding the factors associated with post-COVID conditions is crucial for prevention. A cohort study found that younger age, unvaccinated status, severe initial illness, and comorbidities were associated with a higher risk of persistent post-COVID symptoms. Patients with COVID-19 were also more likely to seek medical care for diabetes, pulmonary, neurological, and mental health-related issues for at least 6 months after symptom onset. These findings can inform COVID-19 vaccination policies.

JAMA NETWORK OPEN (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

Noemi F. Freise, Milena Kivel, Olaf Grebe, Christian Meyer, Bahram Wafaisade, Matthias Peiper, Tobias Zeus, Jan Schmidt, Judith Neuwahl, Danny Jazmati, Tom Luedde, Edwin Boelke, Torsten Feldt, Bjoern Erik Ole Jensen, Johannes Bode, Verena Keitel, Jan Haussmann, Balint Tamaskovics, Wilfried Budach, Johannes C. Fischer, Wolfram Trudo Knoefel, Marion Schneider, Peter Arne Gerber, Alessia Pedoto, Dieter Haeussinger, Martijn van Griensven, Amir Rezazadeh, Yechan Flaig, Julian Kirchner, Gerald Antoch, Hubert Schelzig, Christiane Matuschek

Summary: This study presents a case series of eight patients who developed cardiac symptoms shortly after receiving SARS-CoV-2 mRNA vaccines. Three patients required hospitalization, but all patients fully recovered within seven days. The results suggest that cardiac adverse events such as myocarditis or pericarditis after mRNA vaccination are rare but possible.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

添加到收藏夹

Article Immunology

New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series

Jeong-Hoon Lim, Mee-Seon Kim, Yong-Jin Kim, Man-Hoon Han, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park

Summary: This study reports the clinical courses and histopathologic findings of new-onset kidney diseases after COVID-19 vaccination. The specific types of kidney diseases identified include IgA nephropathy, minimal change disease, thrombotic microangiopathy, and acute tubulointerstitial nephritis. Individualized treatment improved the outcomes of all patients. Clinicians should consider the possibility of vaccine-induced kidney diseases in patients with renal symptoms.

VACCINES (2022)

添加到收藏夹

Article Clinical Neurology

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms A Case Series

Arvid Eden, Nelly Kanberg, Johanna Gostner, Dietmar Fuchs, Lars Hagberg, Lars-Magnus Andersson, Magnus Lindh, Richard W. Price, Henrik Zetterberg, Magnus Gisslen

Summary: The study found evidence of inflammation in the central nervous system of patients with COVID-19 and neurological symptoms, but the typical features of CNS viral infections were absent. There were marked differences in the cerebrospinal fluid of COVID-19 patients compared to other viral CNS infections, raising questions about the pathobiology of SARS-CoV-2 infection in the CNS.

NEUROLOGY (2021)

添加到收藏夹

Article Rehabilitation

Adhesive Capsulitis After COVID-19 Vaccination A Case Series

Srutarshi Ghosh, Sanjay Kumar Pandey, Anurug Biswas, Jyoti Pandey

Summary: This report presents 9 cases of adhesive capsulitis following COVID-19 vaccine administration. Symptoms appeared within 12 days after vaccination and lasted for an average of 9.4 weeks. Treatment with medication and injections improved pain and range of motion. The exact cause remains unclear, but it may be related to shoulder injury caused by vaccine administration.

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series

Christian Baumeier, Ganna Aleshcheva, Dominik Harms, Ulrich Gross, Christian Hamm, Birgit Assmus, Ralf Westenfeld, Malte Kelm, Spyros Rammos, Philip Wenzel, Thomas Muenzel, Albrecht Elsaesser, Mudather Gailani, Christian Perings, Alae Bourakkadi, Markus Flesch, Tibor Kempf, Johann Bauersachs, Felicitas Escher, Heinz-Peter Schultheiss

Summary: Reports of myocarditis following COVID-19 vaccination have been observed since early 2021. Young males are particularly at increased risk, although limited cases with endomyocardial biopsy (EMB) confirmation are available. This study presents histopathological analysis of 15 patients with reduced ejection fraction and clinical suspicion of myocarditis following vaccination. The analysis reveals myocardial inflammation in the majority of patients, suggesting a possible autoimmune response triggered by the vaccine.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Medicine, General & Internal

Case Report: Myocarditis After COVID-19 Vaccination - Case Series and Literature Review

Samuel Nunn, Johannes Kersten, Marijana Tadic, Alexander Wolf, Birgid Gonska, Elina Huell, Hanna Dietenberger, Wolfgang Rottbauer, Dominik Buckert

Summary: This article reports four cases of acute pericarditis/myocarditis following mRNA vaccination. Patients presented with chest pain, fever, and flu-like symptoms. Diagnosis was confirmed through various diagnostic methods, and appropriate treatment was administered. Despite the risks, vaccination remains a positive choice compared to potential SARS-CoV-2 infection.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Immunology

COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series

Zhe Ruan, Yonglan Tang, Chunhong Li, Chao Sun, Ying Zhu, Zhuyi Li, Ting Chang

Summary: This study investigated the safety of COVID-19 vaccination in 22 patients with myasthenia gravis, finding that the majority did not experience symptom worsening within 4 weeks post-vaccination. Most patients received inactivated vaccines and showed no adverse effects, supporting the recommendation for vaccination in MG patients during the ongoing pandemic.

VACCINES (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination

Felipe Sanchez Tijmes, Constantin A. Marschner, Joao Francisco Ribeiro Gavina de Matos, Camila M. Urzua Fresno, Jose Miguel Gutierrez Chacoff, Paaladinesh Thavendiranathan, Cristina Fuss, Kate Hanneman

Summary: COVID-19 and mRNA-based COVID-19 vaccination can lead to acute and longer-term cardiovascular manifestations, including myocardial injury and myocarditis. Noninvasive imaging such as cardiac MRI plays a key role in identifying cardiovascular diseases, evaluating mechanisms of injury, stratifying risk, and guiding treatment.

RADIOGRAPHICS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Persistent symptoms and lab abnormalities in patients who recovered from COVID-19

Julian Varghese, Sarah Sandmann, Kevin Ochs, Inga-Marie Schrempf, Christopher Froemmel, Martin Dugas, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse

Summary: This study found that a majority of recovered COVID-19 patients experience persistent symptoms, with fatigue, dyspnea, and anosmia being the most common. Lymphopenia was a persistent laboratory finding, and patients with this condition were more likely to have persistent symptoms. Additionally, patients with persistent symptoms had significantly lower serum IgA levels, indicating a potential association between lymphopenia and persistence of COVID-19 symptoms.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Medicine, General & Internal

Persistent Symptoms After Acute COVID-19 Infection in Omicron Era

Young Hee Jung, Eun-Hye Ha, Kang Won Choe, Seungbok Lee, Dong Ho Jo, Wang Jun Lee

Summary: This study aims to compare the clinical characteristics and symptoms of the acute and post-acute phases of COVID, finding that persistent symptoms are diverse and involve multiple organs, requiring long-term observation and multidisciplinary interventions.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

添加到收藏夹

Article Medicine, General & Internal

Acute pancreatitis soon after COVID-19 vaccination A case report

Sotaro Ozaka, Takamoto Kodera, Shimpei Ariki, Takashi Kobayashi, Kazunari Murakami

Summary: This article investigates a case of acute pancreatitis following COVID-19 mRNA vaccination, and describes and summarizes the patient's symptoms, diagnosis, and treatment.

MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Risk of COVID-19 after natural infection or vaccination

Anne-Marie Rick, Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas C. S. Martin, Carina A. Rodriguez, Christina A. Rostad, Rebone M. Maboa, Lindsey R. Baden, Hana M. El Sahly, Beatriz Grinsztejn, Glenda E. Gray, Cynthia L. Gay, Peter B. Gilbert, Holly E. Janes, James G. Kublin, Yunda Huang, Brett Leav, Ian Hirsch, Frank Struyf, Lisa M. Dunkle, Kathleen M. Neuzil, Lawrence Corey, Paul A. Goepfert, Stephen R. Walsh, Dean Follmann, Karen L. Kotloff

Summary: This study found that previous infection, hybrid immunity, and vaccination all provide substantial protection against symptomatic and severe COVID-19 during the early Delta period. Hybrid immunity, which combines previous infection with vaccination, is more effective than vaccination alone. Vaccination, previous infection, and hybrid immunity all offer near-complete protection against severe disease.

EBIOMEDICINE (2023)

添加到收藏夹

Letter Medicine, General & Internal

Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection

Alan C. Kwan, Joseph E. Ebinger, Patrick Botting, Jesse Navarrette, Brian Claggett, Susan Cheng

Summary: This cohort study examines the risk of developing hypertension, hyperlipidemia, and diabetes in patients who were vaccinated or unvaccinated before COVID-19 infection.

JAMA NETWORK OPEN (2023)

添加到收藏夹

Review Infectious Diseases

Observational versus randomized controlled trials to inform antibiotic treatment durations: a narrative review

Emily G. McDonald, Connor Prosty, Ryan Hanula, Emilie Bortolussi-Courval, Arthur M. Albuquerque, Steven Y. C. Tong, Fergus Hamilton, Todd C. Lee

Summary: This narrative review compares the strengths and limitations of observational study data with randomized controlled trial (RCT) data in evaluating antibiotic treatment durations. The findings indicate that, in terms of all-cause mortality at 30 days, RCT data provide some support for longer-course therapy, while observational study data show stronger support for longer-course therapy. Observational studies still face challenges in addressing potential sources of bias.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

添加到收藏夹

Article Genetics & Heredity

Variation in ERAP2 has opposing effects on severe respiratory infection and autoimmune disease

Fergus Hamilton, Alexander J. Mentzer, Tom Parks, J. Kenneth Baillie, George Davey Smith, Peter Ghazal, Nicholas J. Timpson

Summary: ERAP2 gene variation is associated with respiratory infection and autoimmune diseases. The T allele of rs2549794 is found to be deleterious during the Black Death epidemic and is also associated with decreased ERAP2 expression and protein levels. The study suggests a balancing selection at this locus driven by autoimmune and infectious diseases.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

添加到收藏夹

Article Infectious Diseases

The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis

Fergus Hamilton, Ruth E. Mitchell, Andrei Constantinescu, David Hughes, Aubrey Cunnington, Peter Ghazal, Nicholas J. Timpson

Summary: Through Mendelian Randomization (MR) analysis using the genetic variant rs2228145, it was found that decreasing IL-6 signaling does not have an effect on the development of severe malaria. This suggests that IL-6 may not be causal for severe outcomes in malaria, and therapeutic manipulation of IL-6 is unlikely to be a suitable treatment for severe malaria.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Letter Medicine, General & Internal

Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection

Fergus Hamilton, William F. Wright, Todd C. Lee

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

Rachel L. Williams, Catherine Hyams, Joe Robertshaw, Maria Garcia Gonzalez, Zsuzsa Szasz-Benczur, Paul White, Nick A. Maskell, Adam Finn, Shaney L. Barratt

Summary: This study investigated the use of CURB-65 and NEWS-2 severity scores in predicting mortality following ARD-ILD hospitalization. The results showed that NEWS-2 had good discriminatory value for predicting in-hospital mortality, while CURB-65 was more suitable for predicting in-hospital and 90-day mortality.

RESPIRATORY MEDICINE (2023)

添加到收藏夹

Article Respiratory System

Investigation and outcomes in patients with nonspecific pleuritis: results from the International Collaborative Effusion database

Anand Sundaralingam, Avinash Aujayeb, Karl A. Jackson, Emilia Pellas, Irfan I. Khan, Muhammad T. Chohan, Roos Joosten, Anton Boersma, Jordy Kerkhoff, Silvia Bielsa, Jose M. Porcel, Ales Rozman, Mateja Marc-Malovrh, Hugh Welch, Jenny Symonds, Stavros Anevlavis, Marios Froudrakis, Federico Mei, Lina Zuccatosta, Stefano Gasparini, Francesca Gonnelli, Inderdeep Dhaliwal, Michael A. Mitchell, Katrine Fjaellegaard, Jesper K. Petersen, Mohamed Ellayeh, Najib M. Rahman, Tom Burden, Uffe Bodtger, Coenraad F. N. Koegelenberg, Nick A. Maskell, Julius Janssen, Rahul Bhatnagar

Summary: This study investigates nonspecific pleuritis (NSP) and its associated etiologies, finding a significant proportion of patients eventually diagnosed with malignant diseases. The most common etiology for NSP is idiopathic (44%), followed by pleural infection (15%), benign asbestos disease (12%), malignancy (6%), and cardiac failure (6%). This study also highlights important areas for future research on NSP.

ERJ OPEN RESEARCH (2023)

添加到收藏夹

Article Health Care Sciences & Services

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study

Anastasia Chatzilena, Catherine Hyams, Rob Challen, Robin Marlow, Jade King, David Adegbite, Jane Kinney, Madeleine Clout, Nick Maskell, Jennifer Oliver, Leon Danon, Adam Finn

Summary: This study assessed the effectiveness of the BNT162b2 vaccine against various clinical indices of COVID-19 severity, including hospitalisation, length of stay >3 days, WHO COVID Score >5, and requirement for supplementary oxygen FiO2 >28%. The results showed that the BNT162b2 vaccine significantly reduced the risk of hospitalisation and severity of COVID-19 following Delta and Omicron infections, particularly in older adults.

LANCET REGIONAL HEALTH-EUROPE (2023)

添加到收藏夹

Article Health Care Sciences & Services

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow, Jennifer Nguyen, Elizabeth Begier, Jo Southern, Jade King, Anna Morley, Jane Kinney, Madeleine Clout, Jennifer Oliver, Sharon Gray, Gillian Ellsbury, Nick Maskell, Luis Jodar, Bradford Gessner, John McLaughlin, Leon Danon, Adam Finn

Summary: This study demonstrates that Omicron infection in hospitalized patients results in lower disease severity compared to the Delta variant. Despite being relatively lower, Omicron infection still imposes a significant burden on patients and public health.

LANCET REGIONAL HEALTH-EUROPE (2023)

添加到收藏夹

Article Anesthesiology

A quantitative evaluation of aerosol generation during cardiopulmonary resuscitation

A. J. Shrimpton, V. Brown, J. Vassallo, J. P. Nolan, J. Soar, F. Hamilton, T. M. Cook, B. R. Bzdek, J. P. Reid, C. H. Makepeace, J. Deutsch, R. Ascione, J. M. Brown, J. R. Benger, A. E. Pickering

Summary: Cardiopulmonary resuscitation generates high concentrations of respiratory aerosol, suggesting the need for airborne transmission precautions in high-risk pathogen settings.

ANAESTHESIA (2023)

添加到收藏夹

Article Medicine, General & Internal

Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults

Catherine Hyams, George Qian, George Nava, Robert Challen, Elizabeth Begier, Jo Southern, Maria Lahuerta, Jennifer L. Nguyen, Jade King, Anna Morley, Madeleine Clout, Nick Maskell, Luis Jodar, Jennifer Oliver, Gillian Ellsbury, John M. McLaughlin, Bradford D. Gessner, Adam Finn, Leon Danon, James W. Dodd

Summary: This study aimed to determine whether acute exacerbations of chronic obstructive pulmonary disease (AECOPD) triggered by SARS-CoV-2 have worse outcomes compared to AECOPD caused by other infectious agents or non-infective AECOPD. The results showed that patients with SARS-CoV-2-related AECOPD had higher rates of positive pressure support, longer hospital stays, and increased mortality compared to non-SARS-CoV-2 infective AECOPD or NI-COPD.

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Challenges in undertaking nonlinear Mendelian randomization

Kaitlin H. Wade, Fergus W. Hamilton, David Carslake, Naveed Sattar, George Davey Smith, Nicholas J. Timpson

Summary: Mendelian randomization (MR) is a commonly used method for strengthening causal inference by utilizing the properties of genetic variation. Nonlinear MR allows estimation of the shape of such relationships. In this study, the authors explore the utility and biases of these nonlinear MR methods using a negative control design.

OBESITY (2023)

添加到收藏夹

Editorial Material Medicine, Research & Experimental

Bad research is not all bad

Fergus Hamilton, David Arnold, Richard Lilford

Summary: This commentary discusses a recent article in Trials that raises concerns about the number of poorly conducted randomized trials in the medical literature and also discusses the trials literature more generally. The authors argue against the notion that most randomized trials are bad and caution against potential negative consequences of increased methodological review during trial development. They propose that trials should be assessed on their individual merits, taking into account the risk of bias but placing it in a broader context, and that policy interventions to improve trial conduct should be evidence-based rather than relying on arbitrary rules.

TRIALS (2023)

添加到收藏夹

Article Medicine, General & Internal

Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance

Katie Ferguson, Matthew Neilson, Rachel Mercer, Jenny King, Kelly Marshall, Hugh Welch, Selina Tsim, Nick A. Maskell, Najib M. Rahman, Matthew Evison, Kevin G. Blyth

Summary: Meso-ORIGINS is an ambitious study that aims to collect 63 matched benign-mesothelioma tissue pairs through longitudinal surveillance and repeat biopsy. It consists of a prospective study and a retrospective cohort study to evaluate recruitment feasibility and technical feasibility, as well as to determine the sample size. Rating: 8 out of 10.

BMJ OPEN (2023)

添加到收藏夹

Article Cell & Tissue Engineering

Diathermy and bone sawing are high aerosol yield procedures OBSERVATIONS FROM A STERILE LAMINAR FLOW ENVIRONMENT

V. Hamilton, S. Sheikh, A. Szczepanska, N. Maskell, F. Hamilton, J. P. Reid, B. R. Bzdek, J. R. D. Murray

Summary: This study quantifies the aerosol exposure in orthopaedic surgeries and suggests additional precautions for diathermy and bone sawing to reduce exposure.

BONE & JOINT RESEARCH (2023)

添加到收藏夹

Article Hematology

Alterations in platelet proteome signature and impaired platelet integrin & alpha;IIb & beta;3 activation in patients with COVID-19

Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, Alice Milne, Phil A. Lewis, Kate J. Heesom, Stuart J. Mundell, Andrew D. Davidson, Alastair W. Poole, Ingeborg Hers

Summary: Patients with COVID-19 have altered platelet function, which is associated with increased risk of thrombosis. Platelet protein expression is different in COVID-19 patients, and platelet functional responses are reduced. Platelets in COVID-19 patients also show increased association with neutrophils. These findings suggest that platelet-driven thromboinflammation may contribute to the increased risk of thrombosis in COVID-19 patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.